Copyright
©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 7, 2007; 13(25): 3517-3522
Published online Jul 7, 2007. doi: 10.3748/wjg.v13.i25.3517
Published online Jul 7, 2007. doi: 10.3748/wjg.v13.i25.3517
Group | Apoptosis rate (%) | P |
1 RhoA,C-siRNA | 19.07 ± 1.78 | Compared with any group (P < 0.01 or P < 0.05) |
2 RhoA-siRNA | 7.13 ± 0.21 | Compared with 4 or 5 group (P < 0.05), compared with 3 group (P > 0.05) |
3 RhoC-siRNA | 8.11 ± 0.17 | Compared with 4 or 5 group (P < 0.05) |
4 siRNA | 1.23 ± 0.11 | Compared with any group (P < 0.01 or P < 0.05) |
5 LY294002 | 9.44 ± 1.28 | Compared with 4 group (P < 0.01) |
- Citation: Sun HW, Tong SL, He J, Wang Q, Zou L, Ma SJ, Tan HY, Luo JF, Wu HX. RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway. World J Gastroenterol 2007; 13(25): 3517-3522
- URL: https://www.wjgnet.com/1007-9327/full/v13/i25/3517.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i25.3517